PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 161 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $153,000 | -69.5% | 21,423 | +14.5% | 0.03% | -65.9% |
| Q3 2019 | $502,000 | +114.5% | 18,716 | +116.7% | 0.09% | +125.6% |
| Q2 2019 | $234,000 | -29.1% | 8,637 | +2.7% | 0.04% | -49.4% |
| Q1 2017 | $330,000 | -12.5% | 8,413 | -47.4% | 0.08% | -24.5% |
| Q2 2016 | $377,000 | – | 15,986 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
| Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
| SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
| HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
| Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
| Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
| Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
| Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |